These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. König SA, Siemes H, Bläker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Köhler B, Koelfen W, Korinthenberg R. Epilepsia; 1994; 35(5):1005-15. PubMed ID: 7925143 [Abstract] [Full Text] [Related]
4. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. König SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, König I, Hehlmann R. Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231 [Abstract] [Full Text] [Related]
8. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA. Gopaul S, Farrell K, Abbott F. Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387 [Abstract] [Full Text] [Related]
13. [Acute fatal liver insufficiency due to valproic acid therapy]. Binek J, Hany A, Egloff B, Heer M. Schweiz Med Wochenschr; 1991 Feb 16; 121(7):228-33. PubMed ID: 2008603 [Abstract] [Full Text] [Related]
14. Do epileptic children treated with valproate have a risk of excessive weight gain? Bosnak M, Dikici B, Haspolat K, Dagli A, Dikici S. J Child Neurol; 2003 Apr 16; 18(4):306; author reply 306. PubMed ID: 12760438 [No Abstract] [Full Text] [Related]
15. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. Serdaroglu G, Tütüncüoglu S, Kavakli K, Tekgül H. J Child Neurol; 2002 Jan 16; 17(1):41-3. PubMed ID: 11913569 [Abstract] [Full Text] [Related]
16. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003. Koenig SA, Buesing D, Longin E, Oehring R, Häussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H, Samii K, Jungck A, Brückner R, Seitz R, Boxtermann W, Weber Y, Knapp R, Richard HH, Weidner B, Kasper JM, Haensch CA, Fitzek S, Hartmann M, Borusiak P, Müller-Deile A, Degenhardt V, Korenke GC, Hoppen T, Specht U, Gerstner T. Epilepsia; 2006 Dec 16; 47(12):2027-31. PubMed ID: 17201699 [Abstract] [Full Text] [Related]
19. Pharmacology of valproic acid in children with severe epilepsy: clearance and hepatotoxicity. Dodson WE, Tasch V. Neurology; 1981 Aug 16; 31(8):1047-50. PubMed ID: 6791048 [Abstract] [Full Text] [Related]